Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy
Crossref DOI link: https://doi.org/10.1245/s10434-018-6413-x
Published Online: 2018-03-07
Published Print: 2018-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Patel, Bhavika K.
Hilal, Talal http://orcid.org/0000-0001-8249-4128
Covington, Matthew
Zhang, Nan
Kosiorek, Heidi E.
Lobbes, Marc
Northfelt, Donald W.
Pockaj, Barbara A.
Text and Data Mining valid from 2018-03-07
Article History
Received: 6 January 2018
First Online: 7 March 2018